A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia

J. E. Mitchell, G. Christenson, J. Jennings, M. Huber, B. Thomas, Claire Pomeroy, J. Morley

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The endogenous opioid system plays an important role in the control of feeding behavior. Previous research has shown that antagonism of endogenous opioids will suppress feeding in certain models in both human and infrahuman species. In the current study, 16 normal-weight bulimic women were treated with low-dose naltrexone, the long-acting, orally active narcotic antagonist, and placebo in a crossover design. The use of the active drug was not associated with a clinically significant reduction in binge eating or vomiting episodes. Suggestions for further research in this area are offered.

Original languageEnglish (US)
Pages (from-to)94-97
Number of pages4
JournalJournal of Clinical Psychopharmacology
Volume9
Issue number2
StatePublished - 1989
Externally publishedYes

Fingerprint

Bulimia
Naltrexone
Double-Blind Method
Cross-Over Studies
Opioid Analgesics
Outpatients
Placebos
Weights and Measures
Narcotic Antagonists
Feeding Behavior
Research
Vomiting
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Mitchell, J. E., Christenson, G., Jennings, J., Huber, M., Thomas, B., Pomeroy, C., & Morley, J. (1989). A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. Journal of Clinical Psychopharmacology, 9(2), 94-97.

A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. / Mitchell, J. E.; Christenson, G.; Jennings, J.; Huber, M.; Thomas, B.; Pomeroy, Claire; Morley, J.

In: Journal of Clinical Psychopharmacology, Vol. 9, No. 2, 1989, p. 94-97.

Research output: Contribution to journalArticle

Mitchell, JE, Christenson, G, Jennings, J, Huber, M, Thomas, B, Pomeroy, C & Morley, J 1989, 'A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia', Journal of Clinical Psychopharmacology, vol. 9, no. 2, pp. 94-97.
Mitchell, J. E. ; Christenson, G. ; Jennings, J. ; Huber, M. ; Thomas, B. ; Pomeroy, Claire ; Morley, J. / A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. In: Journal of Clinical Psychopharmacology. 1989 ; Vol. 9, No. 2. pp. 94-97.
@article{c1b7a55c993649d587f50f64a4d35de4,
title = "A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia",
abstract = "The endogenous opioid system plays an important role in the control of feeding behavior. Previous research has shown that antagonism of endogenous opioids will suppress feeding in certain models in both human and infrahuman species. In the current study, 16 normal-weight bulimic women were treated with low-dose naltrexone, the long-acting, orally active narcotic antagonist, and placebo in a crossover design. The use of the active drug was not associated with a clinically significant reduction in binge eating or vomiting episodes. Suggestions for further research in this area are offered.",
author = "Mitchell, {J. E.} and G. Christenson and J. Jennings and M. Huber and B. Thomas and Claire Pomeroy and J. Morley",
year = "1989",
language = "English (US)",
volume = "9",
pages = "94--97",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia

AU - Mitchell, J. E.

AU - Christenson, G.

AU - Jennings, J.

AU - Huber, M.

AU - Thomas, B.

AU - Pomeroy, Claire

AU - Morley, J.

PY - 1989

Y1 - 1989

N2 - The endogenous opioid system plays an important role in the control of feeding behavior. Previous research has shown that antagonism of endogenous opioids will suppress feeding in certain models in both human and infrahuman species. In the current study, 16 normal-weight bulimic women were treated with low-dose naltrexone, the long-acting, orally active narcotic antagonist, and placebo in a crossover design. The use of the active drug was not associated with a clinically significant reduction in binge eating or vomiting episodes. Suggestions for further research in this area are offered.

AB - The endogenous opioid system plays an important role in the control of feeding behavior. Previous research has shown that antagonism of endogenous opioids will suppress feeding in certain models in both human and infrahuman species. In the current study, 16 normal-weight bulimic women were treated with low-dose naltrexone, the long-acting, orally active narcotic antagonist, and placebo in a crossover design. The use of the active drug was not associated with a clinically significant reduction in binge eating or vomiting episodes. Suggestions for further research in this area are offered.

UR - http://www.scopus.com/inward/record.url?scp=0024509767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024509767&partnerID=8YFLogxK

M3 - Article

C2 - 2656781

AN - SCOPUS:0024509767

VL - 9

SP - 94

EP - 97

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 2

ER -